Method & assumptions
How every number on this site is produced, and every assumption with its range, confidence, and reasoning.
Approach
- Baseline. Start from the CMS National Health Expenditure Accounts for 2024 (released December 2025): spending by type of service and source of funds (Table 4), and by sponsor (Tables 5-1 to 5-4). Every baseline number is transcribed, not estimated.
- Steady state in 2024 dollars. Ask what 2024 would have looked like with the fully phased-in plan, instead of projecting to a future year. Projections compound uncertainty about growth that has nothing to do with the plan. To approximate a future year, scale by NHE growth (CMS projects about 5–6% a year).
- Re-price each service.For each service, divide each payer's spending by that payer's price relative to a reference price (usually Medicare) to get “reference-price volume”. Multiply by the UHP payment rate (price effect), then by a utilization multiplier (utilization effect). Spending that stays outside UHP (Other insurance programs (CHIP, DoD, VA); other third-party payers & programs; non-covered out-of-pocket items) carries over unchanged.
- Administration.Insurer and plan overhead (the “net cost of insurance”) is removed except for continuing programs; UHP administration is added as a share of benefits.
- Sources of funds. Every 2024 sponsor line is marked as continuing, redirected, reduced, or eliminated, and new taxes are computed from their bases and rates. Whatever remains is reported as an explicit general-revenue line, so sources always equal uses.
- Scenarios. The costly and lean cases change provider rates, induced demand, drug prices, administrative cost, wage pass-through, and top-end revenue together, to bracket the uncertainty.
- Transition. One-time costs and the phase-in financing gap are reported separately from the steady-state ledger.
Service-level assumptions
| Service | Reference price | Private | Medicare | Medicaid | Out of pocket | UHP rate | Utilization | OOP retained |
|---|---|---|---|---|---|---|---|---|
| Hospital care | Medicare fee-for-service rates | 2.20 | 1.00 | 0.90 | 1.60 | 1.20 | 1.04× | 0% |
| Physician & clinical services | Medicare Physician Fee Schedule | 1.40 | 1.00 | 0.72 | 1.30 | 1.12 | 1.12× | 0% |
| Other professional services | Medicare fee schedule | 1.30 | 1.00 | 0.75 | 1.20 | 1.10 | 1.15× | 25% |
| Dental services | Average 2024 private-insurance dental fee | 1.00 | 1.00 | 0.60 | 1.15 | 0.95 | 1.35× | 20% |
| Other health, residential & personal care | Average 2024 Medicaid waiver rates | 1.10 | 1.00 | 1.00 | 1.10 | 1.05 | 1.10× | 30% |
| Home health care | Medicare home health rates | 1.10 | 1.00 | 0.85 | 1.00 | 1.00 | 1.20× | 20% |
| Nursing facilities & continuing-care communities | Blended Medicare/Medicaid nursing facility rate | 1.20 | 1.30 | 0.85 | 1.10 | 1.00 | 1.05× | 45% |
| Retail prescription drugs | Medicare Part D net price (after rebates) | 1.00 | 1.00 | 0.70 | 1.20 | 0.72 | 1.08× | 5% |
| Durable medical equipment | Medicare competitive-bidding prices | 1.20 | 1.00 | 0.80 | 1.30 | 0.95 | 1.25× | 40% |
| Other non-durable medical products | Retail price | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00× | 100% |
Private insurers paid roughly 254% of Medicare for hospital services in 2022 (RAND round 5); we use 220% to blend in lower-paying Marketplace and Medicare Advantage-adjacent contracts. Medicaid pays below Medicare on base rates but closer to it once supplemental and directed payments are counted, so 90%. UHP pays 120% of Medicare because MedPAC finds Medicare fee-for-service margins negative for the average hospital (about -13% in 2023); 120% approximately covers the average efficient hospital's costs once billing overhead falls. Inpatient care is not very price-sensitive, so utilization rises only 4%.
Commercial physician prices average about 140% of Medicare (higher for specialists, near 120% for primary care). Medicaid's fee index is about 0.72× of Medicare. UHP pays an average of 112% of Medicare, weighted toward primary care (125%) and away from procedures (105%). Removing deductibles and copays and covering 28 million uninsured people raises visits by roughly 12%, consistent with RAND Health Insurance Experiment elasticities and Oregon Medicaid experiment results.
Physical therapy, mental-health counseling, optometry. A quarter of today's out-of-pocket spending in this category (elective chiropractic, massage, and therapy beyond clinical-necessity limits) stays out of pocket. Mental-health and therapy demand is highly price-sensitive, so utilization rises 15%.
Adult dental is the largest new benefit. Medicaid dental fees average about 60% of private fees. Cosmetic work and adult orthodontics (about 20% of today's out-of-pocket dental spending) stay out of pocket. About 40% of adults skip dental care today because of cost, so utilization rises 35%.
Home- and community-based services (HCBS) become an entitlement instead of a capped Medicaid waiver with waiting lists (about 700,000 people were on HCBS waiting lists in 2023). Rates rise 5% to raise direct-care worker pay. Non-medical help (housekeeping) stays out of pocket.
Medicare's home-health payment becomes the national rate. Utilization rises 20% because long-term home care is covered without the Medicaid asset test.
UHP pays for the clinical and personal-care component of nursing-home stays. Residents still contribute toward room and board on an income-tested scale, as in Canadian provinces; we estimate that keeps 45% of today's out-of-pocket nursing spending out of pocket. Medicare's short-stay rates are about 30% above the blended reference rate; Medicaid's are about 15% below it.
A single national formulary negotiating every brand drug cuts brand net prices about 35% (still above the 2-3x lower prices in other wealthy countries, RAND 2024). Generics, about 20% of spending, stay at today's price. 0.8 x 0.65 + 0.2 x 1.0 = 0.72. Medicaid already gets mandatory rebates, so it pays about 70% of the reference price. Removing copays raises fills 8%, mostly adherence to chronic medications. Drugs not on the formulary stay out of pocket (5%).
Basic eyeglasses and hearing aids become covered. Designer frames, premium hearing aids, and convenience items (40% of today's out-of-pocket spending) remain out of pocket. Utilization rises 25%, mostly for hearing aids: only about 30% of adults over 70 who would benefit from one have one.
Over-the-counter products stay out of pocket, as they do in nearly every universal system. The small Medicare amount (supplies tied to covered conditions) continues under UHP.
Other assumptions
| Assumption | Central | Range | Confidence |
|---|---|---|---|
UHP administrative cost as a share of benefit payments Traditional Medicare spends about 1.4% on administration but is widely considered to under-invest in fraud prevention. Canada's provincial plans spend about 1.5–2.5%. We budget 2.5% to fund program integrity, appeals, a modern claims system, and regional offices. | 2.5% | 1.8% – 3.5% | medium confidence |
Recurring workforce capacity investment Pays for 14,000 residency slots at $150,000 each, 10,000 nursing faculty, 60,000 clinical placements, 32,000 tuition-free service scholars, and 60,000 community health workers. Without it, the utilization increase turns into longer waits. | $12.0B | $8.0B – $20.0B | medium confidence |
Public health increase Held flat so the ledger isolates the coverage change. A public-health increase is a separate policy choice. | $0.0B | $0.0B – $30.0B | high confidence |
Wages & salaries, 2024 BEA National Income and Product Accounts, wages and salaries, 2024. Sources: BEA via FRED (2025) | $12.39T | — | high confidence |
Share of payroll exempted by the small-employer phase-in The first $250,000 of each employer's annual payroll is taxed at a reduced rate. Firms under 10 employees pay about 11% of total payroll; the reduction removes roughly 6% of the total wage base. Sources: U.S. Census Bureau (2022) | 6.0% | 4.0% – 10.0% | medium confidence |
Employer health payroll tax rate A policy choice, not an estimate. 7.5% of payroll raises less than employers paid in premiums in 2024 for those who offered coverage, but it falls on every employer, including the 40%+ of small firms that offer nothing today. | 7.5% | 7.0% – 9.0% | high confidence |
Adjusted gross income above the household exemption AGI was $15.1T in tax year 2022 (IRS SOI) and grows to about $16.0T in 2024. Exempting the first $32,000 of a household's income (scaled by household size) removes about $3.2T, since most low-income returns use all of their exemption. Sources: IRS Statistics of Income (2024) | $12.81T | $12.00T – $13.60T | medium confidence |
Income-based household health premium A policy choice, not an estimate. 4% of AGI above the exemption, collected through income tax withholding. | 4.0% | 3.5% – 5.0% | high confidence |
Share of employer premium savings passed through to cash wages Economists broadly find that employer health costs come out of wages over time. We assume 85% of net employer savings reach paychecks within a few years, enforced in years 1-3 by a maintenance-of-compensation requirement. The remaining 15% stays with employers as profit. | 85.0% | 60.0% – 100.0% | medium confidence |
Average federal income tax rate on newly taxable compensation Once health premiums disappear, compensation that was tax-free shows up as taxable wages. 18% is a blended federal income tax rate for the middle-income workers who receive most of it. Sources: Congressional Budget Office (2024) | 18.0% | 15.0% – 22.0% | medium confidence |
Average state income tax rate on newly taxable compensation Weighted across states, including the nine with no wage income tax. | 3.5% | 2.0% – 5.0% | medium confidence |
Medicare HI payroll tax on newly taxable wages Existing law: 1.45% employer + 1.45% employee. | 2.9% | — | high confidence |
Social Security payroll tax on newly taxable wages Existing law. This revenue goes to the Social Security trust funds, not health care, so it appears as a side effect outside the health ledger. | 12.4% | — | high confidence |
State premium taxes on health insurers lost States tax insurance premiums at roughly 1-3%, but self-insured employer plans (about 60% of covered workers) are exempt under ERISA. About $18B of the private insurers' non-medical spending is state premium tax. | $18.0B | $12.0B – $25.0B | low confidence |
Private health insurer profit (underwriting + fees) Health insurers earned roughly 2-3% pre-tax margins on premiums in 2023-2024, and ASO fees on self-insured plans add more. Earnings at UnitedHealthcare, Elevance, Cigna, Aetna, Humana, Centene, and Molina were squeezed in 2024 by higher medical costs. Sources: NAIC (2024) | $42.0B | $30.0B – $55.0B | low confidence |
Broker and agent commissions and marketing Commissions typically run 2-5% of premium in group markets and are a flat fee per member in the individual market. We assume about 2% of private premiums. | $32.0B | $25.0B – $45.0B | low confidence |
State maintenance-of-effort payment, as a share of 2024 state Medicaid & CHIP spending A policy choice. States keep paying what they paid for Medicaid and Medicare buy-ins, indexed to growth (like the Medicare Part D 'clawback'). They are released from Medicaid's administrative costs and gain income-tax revenue, so most states still come out ahead. | 100.0% | 85.0% – 100.0% | high confidence |
Revenue from top-end measures A 7% surtax on AGI above $1 million (about $1.9T of income in 2024: roughly $135B), taxing capital gains and dividends as ordinary income above $1 million ($90B), and a 0.1% financial transactions tax ($75B after behavioral response). The remaining ~$30B comes from capping the new employer tax deduction for health spending by the largest employers (no longer needed). Every one of these has wide uncertainty, mostly from behavior and avoidance. | $330.1B | $250.0B – $420.0B | low confidence |
How this compares with other estimates
| Study | Finding |
|---|---|
| CBO (2020) | Five single-payer options: national spending in 2030 from −$0.7T to +$0.3T; federal subsidies +$1.5T to +$3.0T. |
| Mercatus / Blahous (2018) | +$32.6T federal over 2022–2031; national spending roughly flat if providers are paid Medicare rates. |
| Urban Institute (2019) | +$34T federal over 2020–2029; national spending up about $7T over 10 years. |
| PERI / Pollin (2018) | National spending 10% lower. |
| Galvani et al., Lancet (2020) | 13% ($450B) savings a year; 68,000 lives saved. |
| This site, central | National spending −1.6%; the costly and lean cases are on the ledger page. |
Most of the difference between estimates comes from two assumptions: provider payment rates and induced utilization. This site shows both explicitly so they can be argued about directly.
Which assumptions matter most
| Assumption | Low → national spending | High → national spending | Low → revenue need | High → revenue need |
|---|---|---|---|---|
Induced demand (scale of utilization increase) 0.75× to 1.5× | −$89.6B | +$179.2B | −$89.6B | +$179.2B |
Hospital payment rate (× Medicare) 1.10 to 1.35 | −$114.4B | +$171.7B | −$114.4B | +$171.7B |
Employer payroll tax rate 7.0% to 9.0% | $0.0B | $0.0B | +$48.0B | −$144.2B |
Household premium rate 3.5% to 5.0% | $0.0B | $0.0B | +$64.0B | −$128.1B |
Physician payment rate (× Medicare) 1.05 to 1.25 | −$67.6B | +$125.5B | −$67.6B | +$125.5B |
Top-end tax revenue $250B to $420B | $0.0B | $0.0B | +$80.1B | −$89.9B |
Drug prices (× today's Medicare net) 0.65 to 0.85 | −$35.3B | +$65.5B | −$35.3B | +$65.5B |
UHP administrative cost 1.8% to 3.5% | −$27.0B | +$38.6B | −$27.0B | +$38.6B |
Household premium base (AGI above exemption) $12000B to $13600B | $0.0B | $0.0B | +$32.2B | −$31.8B |
Payroll exempted for small employers 4.0% to 10.0% | $0.0B | $0.0B | −$15.3B | +$30.6B |
Tax rate on newly taxable wages 15.0% to 22.0% | $0.0B | $0.0B | +$15.9B | −$21.2B |
Employer savings passed to wages 60.0% to 100.0% | $0.0B | $0.0B | +$9.0B | −$5.4B |
Workforce investment $8B to $20B | −$4.0B | +$8.0B | −$4.0B | +$8.0B |